Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment by J. Schäfer, G. Welzel, F. Wenz on D. Norkus et al. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma. a report on acute toxicity : in: Strahlenther Onkol 2009;185: 715-21 (No. 11) (DOI 10.1007/s00066-009-1982-z).

× No keyword cloud information.

11 in total

Review 1. Hypofractionation for prostate cancer: a critical review.

Authors: Edward F Miles; W Robert Lee
Journal: Semin Radiat Oncol Date: 2008-01 Impact factor: 5.934

2. Lessons from and cautions about noninferiority and equivalence randomized trials.

Authors: Peter C Gøtzsche
Journal: JAMA Date: 2006-03-08 Impact factor: 56.272

3. Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

Authors: Frederick Marc Köhler; Judit Boda-Heggemann; Beate Küpper; Dirk Wolff; Hansjörg Wertz; Frank Lohr; Frederik Wenz
Journal: Strahlenther Onkol Date: 2009-02-18 Impact factor: 3.621

4. Fractionation and protraction for radiotherapy of prostate carcinoma.

Authors: D J Brenner; E J Hall
Journal: Int J Radiat Oncol Biol Phys Date: 1999-03-15 Impact factor: 7.038

5. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.

Authors: Eric E K Yeoh; Robert J Fraser; Roz E McGowan; Rochelle J Botten; Addolorata C Di Matteo; Daniel E Roos; Michael G Penniment; Martin F Borg
Journal: Int J Radiat Oncol Biol Phys Date: 2003-03-15 Impact factor: 7.038

Review 6. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.

Authors: Jack F Fowler
Journal: Acta Oncol Date: 2005 Impact factor: 4.089

7. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.

Authors: Markus Bohrer; Peter Schröder; Grit Welzel; Hansjörg Wertz; Frank Lohr; Frederik Wenz; Sabine Kathrin Mai
Journal: Strahlenther Onkol Date: 2008-12-24 Impact factor: 3.621

8. What hypofractionated protocols should be tested for prostate cancer?

Authors: Jack F Fowler; Mark A Ritter; Rick J Chappell; David J Brenner
Journal: Int J Radiat Oncol Biol Phys Date: 2003-07-15 Impact factor: 7.038

9. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer.

Authors: Scott G Williams; Jeremy M G Taylor; Ning Liu; Yolande Tra; Gillian M Duchesne; Larry L Kestin; Alvaro Martinez; Gary R Pratt; Howard Sandler
Journal: Int J Radiat Oncol Biol Phys Date: 2007-05-01 Impact factor: 7.038

10. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.

Authors: Mark Ritter
Journal: Semin Radiat Oncol Date: 2008-10 Impact factor: 5.934

1 in total

1. Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors: Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal: Strahlenther Onkol Date: 2010-09-30 Impact factor: 3.621

1 in total